038290 Macrogen

Macrogen Established Its Branch in Spain, Strengthening Localization Service in Europe

SEOUL, South Korea--(BUSINESS WIRE)--

Macrogen Inc. (CEO Hyon-yong Chong, www.macrogen.com) (KOSDAQ:038290), a precision medicine biotechnology company, announced on Sept. 4 that it will begin providing localization service in September at its branch in Madrid, Spain.

The Spanish branch of Macrogen was established last December following its first European branch in Amsterdam, Netherlands. This branch will provide quick and customer-friendly services to Southern Europe and the MENA (Middle East and North Africa) area to meet the rising demand. Macrogen is the world’s first genome sequencing company to establish an overseas branch in Spain and provide localization services.

The Spanish branch of Macrogen has been providing a trial service to existing customers in Southern Europe and the MENA area since February and will provide regular services in the second half of the year. Approximately 1,800 research institutions, as of the end of August, have utilized Macrogen’s services.

Macrogen’s CEO Hyon-yong Chong stated, “It is difficult for the existing branch in the Netherlands to support all customers in Europe because of the increasing demand from European customers.” He added, “Customers of Northern Europe will be able to use the Netherlands branch, while customers of Southern Europe and the MENA area will be able to quickly and conveniently access Macrogen’s industry-leading genome sequencing services through the Spanish branch.”

Macrogen is continuously establishing a “global genome center network” in important overseas locations in a localization strategy to provide quicker and customer-friendly services. In addition to the recently opened branch in Spain, Macrogen has been stably operating the services in the USA (Rockville, Md., New York, Boston) since 2005, Japan (Tokyo, Kyoto) since 2007, the Netherlands (Amsterdam) since 2008, Oceania (Sydney, Australia) since 2013, and Singapore since 2016.

The Spanish branch of Macrogen is planning to host a customer appreciation event that includes special monthly gifts to their best customers from September to the end of the year to celebrate their official service launch in Southern Europe and the MENA area.

Contact Us for Services

Macrogen Spain

+34-911-138-378 [email protected]

Avda. Sur del Aeropuerto, 28, 28042 Madrid, Spain

EN
04/09/2017

Underlying

038290Macrogen

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Macrogen

 PRESS RELEASE
Free
038290 MACROGEN

Macrogen Licenses Gene Editing Technology from Broad Institute of MIT ...

SEOUL, South Korea--(BUSINESS WIRE)-- Macrogen, Inc. (CEO Ji-young Moon, www.macrogen.com) (KOSDAQ: 038290), a precision medicine biotechnology company, announced on April 5 that it has acquired a non-exclusive commercial research tool license to CRISPR-Cas9 technology from the Broad Institute of MIT and Harvard in the USA, and said that the company’s gene editing technical portfolio has been further strengthened by licensing of this technology. Macrogen has acquired around 50 technologies, including the CRISPR-Cas9 portfolio...

April 5, 2018 1 EN
 PRESS RELEASE
Free
038290 MACROGEN

Macrogen Corp.'s Clinical NGS Laboratory Receives CAP Accreditation

ROCKVILLE, Md.--(BUSINESS WIRE)-- Macrogen Corp. (www.macrogenlab.com) announces that its Clinical Lab that provides clinical NGS services has been awarded accreditation by the Accreditation Committee of the College of American Pathologists (CAP) based on results of a recent on-site inspection as part of the CAP’s Accreditation Programs. “Macrogen demonstrates leadership, innovation, and a passionate commitment to standards of excellence while providing the highest quality services, ultimately for patients,” said Bharati Jhav...

November 15, 2017 1 EN
 PRESS RELEASE
Free
038290 MACROGEN

Le laboratoire d’analyses NGS de Macrogen Corp. reçoit l’accré...

ROCKVILLE, Maryland--(BUSINESS WIRE)-- Macrogen Corp. (www.macrogenlab.com) annonce que son laboratoire d’analyses qui fournit des services cliniques NGS a été accrédité par le Comité d’accréditation du College of American Pathologists (CAP), suite aux résultats d’une récente inspection effectuée sur place dans le cadre des Programmes d’accréditation, du CAP. « Macrogen témoigne de son leadership, de ses innovations et de son engagement passionné à respecter les normes d’excellence tout en fournissant des services de q...

November 15, 2017 1 FR
 PRESS RELEASE
Free
038290 MACROGEN

Macrogen Established Its Branch in Spain, Strengthening Localization S...

SEOUL, South Korea--(BUSINESS WIRE)-- Macrogen Inc. (CEO Hyon-yong Chong, www.macrogen.com) (KOSDAQ:038290), a precision medicine biotechnology company, announced on Sept. 4 that it will begin providing localization service in September at its branch in Madrid, Spain. The Spanish branch of Macrogen was established last December following its first European branch in Amsterdam, Netherlands. This branch will provide quick and customer-friendly services to Southern Europe and the MENA (Middle East and North Africa) area t...

September 4, 2017 1 EN
 PRESS RELEASE
Free
038290 MACROGEN

Macrogen a établi une succursale en Espagne, afin de renforcer son se...

SÉOUL, Corée du Sud--(BUSINESS WIRE)-- Macrogen Inc. (CEO Hyon-yong Chong, www.macrogen.com) (KOSDAQ : 038290), une société de biotechnologie médicale de précision, a annoncé le 4 septembre que dès septembre elle offrirait, depuis sa succursale de Madrid en Espagne, un service de localisation. La succursale espagnole de Macrogen a été créée en décembre dernier après l’ouverture de sa première branche européenne à Amsterdam, aux Pays-Bas. Cette succursale fournira des services rapides et adaptés aux clients du sud de ...

September 4, 2017 1 FR

ResearchPool Subscriptions

Get the most out of your insights

Get in touch